Standout Papers
- Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. (1998)
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2015)
- XRCC1 Polypeptide Interacts with DNA Polymerase and Possibly Poly (ADP-Ribose) Polymerase, and DNA Ligase III Is a Novel Molecular 'Nick-Sensor' In Vitro (1996)
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma (2015)
- Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study (2021)
- Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study (2021)
Immediate Impact
17 by Nobel laureates 23 from Science/Nature 62 standout
Citing Papers
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study
2023 Standout
T-cell-engaging bispecific antibodies in cancer
2023 Standout
Works of Peter Johnson being referenced
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2021 Standout
Mogamulizumab and the Treatment of Ccr4-Positive T-Cell Lymphomas
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Johnson | 7598 | 6892 | 7350 | 604 | 23.3k | |
| Michael Pfreundschuh | 9849 | 6487 | 8124 | 419 | 20.2k | |
| John P. Leonard | 9244 | 3070 | 6569 | 483 | 16.8k | |
| Andreas Engert | 11883 | 4065 | 9034 | 551 | 20.2k | |
| Stephen M. Ansell | 13439 | 8639 | 14660 | 732 | 25.9k | |
| Bernd Dörken | 4708 | 4976 | 8532 | 412 | 21.6k | |
| Volker Diehl | 17115 | 6166 | 13770 | 688 | 30.6k | |
| Ranjana H. Advani | 12994 | 4473 | 9864 | 450 | 19.3k | |
| Lars Klareskog | 4134 | 13668 | 4167 | 653 | 41.5k | |
| Leo I. Gordon | 7793 | 2105 | 6440 | 439 | 14.6k | |
| Steven T. Rosen | 6377 | 3183 | 5606 | 413 | 15.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...